Novartis has submitted marketing authorization applications in the United States and Europe for the use of Femara? (letrozole) in the adjuvant (post-surgery) treatment of postmenopausal women with hormone receptor-positive early breast cancer.
Researchers at the University of Minnesota Cancer Center and the National Cancer Institute (NCI), part of the National Institutes of Health, have discovered a new method that could accelerate the way cancer-causing genes are found and lead to a more accurate identification of the genes, according to two studies in the July 14, 2005 issue of Nature.
Under the Food and Drug Administration’s (FDA) “Consumer Health for Better Nutrition Initiative,” the Agency is announcing the results of a review of qualified health claims that green tea may reduce the risk of certain types of cancer. Based on a systematic evaluation of the available scientific data, the FDA intends to consider exercising its enforcement discretion for the following qualified health claims for breast and prostate cancer:
In patients with locally advanced prostate cancer, a three-pronged approach to therapy can achieve a high level of tumor control, researchers at the University of Virginia in Charlottesville report.
A drug shown to be more effective than the previous “gold standard” treatment for early-stage breast cancer sufferers becomes available to patients.
New research under the direction of Paul Khavari, MD, PhD, professor in the Program in Epithelial Biology at the Stanford University School of Medicine and chief of the dermatology service at the Veterans Affairs Palo Alto Healthcare System, shows a novel and more effective way of testing which mutations cause cancer and which are mere research distractions. The work is published in the June issue of Nature Genetics.
A hand-held imaging device designed for use at home appears effective in detecting breast cancer in its early stages, according to a University of Pennsylvania researcher who hopes the device might be available commercially to women in a year or two.
Even very low levels of a chemical found in plastic containers and tin cans boosts risks for prostate abnormalities in mice, and may do so in humans as well, researchers report.
New studies in the Linus Pauling Institute at Oregon State University have shown that vitamin E disappears more quickly in smokers than in non-smokers – findings that may help explain how smoking can cause cancer.
Having someone to talk with who has been there can make that mind-numbing diagnosis of breast cancer somewhat bearable.